Multi-Peptide Lash Serum: undeclared ingredient and sold without market authorization
Last updated
Summary
Product
Multi-Peptide Lash Serum
Issue
Health products - Product quality
Health products - Unauthorized product
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Multi-Peptide Lash Serum |
Multi-Peptide Lash Serum |
Not licensed |
Liquid |
Bimatoprost |
20221230 |
Issue
Affected lots contain an undeclared ingredient (bimatoprost). Product sold without market authorization (DIN) in Canada.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Linger Beauty
4974 Kingsway Ave, Box 425
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74164
Get notified
Receive notifications for new and updated recalls and alerts by category.